Science

…psilocybin could be powerful… for pain – without opioids’ dwindling effects over time, study says

“Recent neuroimaging studies combined with small sample interventions with classic psychedelic agents,” authors wrote, “may point towards a possible means of improving the treatment of chronic pain on a mechanistic and experiential level.” Numerous small trials of… psilocybin for chronic pain have already shown a good safety profile, with minimal physical dependence, withdrawal syndrome, or…

READ MORE
Science

Psilocybin’s ‘efficacy and safety’ for bipolar II depression demonstrated by American medical association study

“12 patients met both response and remission criteria” at the end of a 12-week study period, the trial found, meaning that measures of the diagnosis had dropped by more than half and fell below a minimum threshold. Results… published by the American Medical Association “suggest efficacy and safety” of psilocybin-assisted psychotherapy for treatment of bipolar…

READ MORE
Science

Psychedelic mushroom use linked to lower psychological distress in those with adverse childhood experiences

…researchers have uncovered a potentially promising connection between the use of psychedelic mushrooms and a reduction in psychological distress, particularly among individuals who have experienced adverse childhood experiences. The study was published in the Journal of Psychoactive Drugs. …study aimed to explore the relationship between psilocybin use and psychological distress, with a specific focus on individuals…

READ MORE
Politics

Ukraine: ecstasy, mushrooms to fight war trauma

…calls to permit their use in psychotherapy have been growing in Ukraine following Russia’s full-scale invasion. Experts in Ukraine are appealing to parliament to facilitate the therapeutic use of these substances. Ksenia Voznitsyna, director of the Ukrainian Health Ministry’s Center for Veterans’ Mental Health and Rehabilitation, is a leading voice in the campaign. “We are…

READ MORE
Medicine/Healing

Federal appeals court rules against DEA In psilocybin rescheduling lawsuit brought by doctor who wants to give psychedelic to cancer patients

A federal appeals court has ruled against the Drug Enforcement Administration (DEA) in a lawsuit over a Washington State doctor’s petition to reschedule psilocybin. The court said DEA failed to explain its reasoning when it denied the petition, and it ordered the agency to provide a more complete justification… “Given the inadequacy of the DEA’s denial…

READ MORE
Biography/Memoir

…story… seriously…

…while memes and social media played up on the mushroom angle, most the content failed to mention that Emerson also told law enforcement that he hadn’t slept for more than forty hours, and that it had actually been two days since he had eaten those shrooms. The national stories have made no mention of toxicology…

READ MORE